Final Policy: Updates to Uniform Standard for Waiver of the Ryan White HIV/AIDS Program Core Medical Services Expenditure Requirement, 54458-54462 [2021-21241]
Download as PDF
54458
Federal Register / Vol. 86, No. 188 / Friday, October 1, 2021 / Notices
TABLE 1—LIST OF INFORMATION COLLECTIONS APPROVED BY OMB
OMB control
No.
Title of collection
Blood Establishment Registration and Product Listing for Manufacturers of Blood and Blood Products and Licensed Devices ....................................................................................................................................................
Current Good Manufacturing Practice: Manufacturing, Processing, Packing, and Holding of Drugs; GMP for
Finished Pharmaceuticals (Including Gases and Active Pharmaceutical Ingredients) .......................................
Irradiation in the Production, Processing, and Handling of Food ...........................................................................
State Enforcement Notifications ..............................................................................................................................
Veterinary Feed Directive ........................................................................................................................................
Record Retention Requirements for the Soy Protein/Coronary Heart Disease Health Claim ................................
Prescription Drug Marketing: Administrative Procedures, Policies, and Requirements .........................................
Generic Clearance for the Collection of Qualitative Data on Tobacco Products and Communications ................
Survey of Drug Product Manufacturing, Processing, and Packing Facilities ..........................................................
Current Good Manufacturing Practices for Blood and Related Regulations for Blood Components; and Requirements for Donor Testing, Donor Notification and ‘‘Lookback’’ ....................................................................
New Animal Drugs for Investigational Use ..............................................................................................................
Regulations Under the Federal Import Milk Act ......................................................................................................
Medical Device Reporting ........................................................................................................................................
New Plant Varieties Intended for Food Use ............................................................................................................
Guidance for Industry and FDA Staff; Class II Special Controls: Automated Blood Cell Separator Device Operating by Centrifugal or Filtration Separation Principle .........................................................................................
Prescription Drug Advertisements ...........................................................................................................................
Animal Food Labeling; Declaration of Certifiable Color Additives ..........................................................................
Survey on the Occurrence of Foodborne Illness Risk Factors in Selected Retail and Food Service Facility
Types ....................................................................................................................................................................
Food and Cosmetic Export Certificates ...................................................................................................................
National Agriculture and Food Defense Strategy Survey .......................................................................................
Medical Product Communications That are Consistent With the Food and Drug Administration Required Labeling—Questions and Answers ...............................................................................................................................
Drug and Device Manufacturer Communications with Payors, Formulary Committees, and Similar Entities
Questions and Answers .......................................................................................................................................
Study of Disclosures to Health Care Providers Regarding Data That Do Not Support Unapproved Use of an
Approved Prescription Drug .................................................................................................................................
Medical Conference Attendees’ Observations About Prescription Drug Promotion ...............................................
Dated: September 24, 2021.
Lauren K. Roth,
Acting Principal Associate Commissioner for
Policy.
[FR Doc. 2021–21386 Filed 9–30–21; 8:45 am]
BILLING CODE 4164–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Health Resources and Services
Administration
Final Policy: Updates to Uniform
Standard for Waiver of the Ryan White
HIV/AIDS Program Core Medical
Services Expenditure Requirement
Health Resources and Services
Administration (HRSA), Department of
Health and Human Services (HHS).
ACTION: Notice of final policy.
AGENCY:
The Ryan White HIV/AIDS
Program (RWHAP) statute of the Public
Health Services Act requires that
RWHAP Part A, B, and C recipients
expend not less than 75 percent of Parts
A, B, and C grant funds on core medical
services for individuals with HIV/AIDS
identified and eligible under the statute,
after reserving statutory permissible
SUMMARY:
VerDate Sep<11>2014
18:04 Sep 30, 2021
Jkt 256001
amounts for administrative and clinical
quality management (CQM) costs. The
statute also grants the Secretary of HHS
authority to waive this requirement if
certain requirements are met. HRSA has
simplified the process for RWHAP Part
A, B, and C recipients to request a
waiver of the core medical services
expenditure amount requirement by
replacing HRSA Policy Number 13–07,
‘‘Uniform Standard for Waiver of Core
Medical Services Requirement for
Grantees Under Parts, A, B, and C’’ with
Policy Notice 21–01, ‘‘Waiver of the
Ryan White HIV/AIDS Program Core
Medical Services Expenditure
Requirement.’’
DATES: The final policy is effective on
October 1, 2021.
FOR FURTHER INFORMATION CONTACT:
Lieutenant Commander Emeka Egwim,
U.S. Public Health Service, Senior
Policy Analyst, Division of Policy &
Data, HRSA, HIV/AIDS Bureau, 5600
Fishers Lane, Rockville, MD 20857,
Phone: (301) 945–9637 or by emailing
RWHAPPolicy@hrsa.gov. When
requesting information, please include
this Federal Register notice title for
reference.
SUPPLEMENTARY INFORMATION: The
RWHAP statute also grants the Secretary
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
Date approval
expires
0910–0052
7/31/2024
0910–0139
0910–0186
0910–0275
0910–0363
0910–0428
0910–0435
0910–0796
0910–0899
7/31/2024
7/31/2024
7/31/2024
7/31/2024
7/31/2024
7/31/2024
7/31/2024
7/31/2024
0910–0116
0910–0117
0910–0212
0910–0437
0910–0583
8/31/2024
8/31/2024
8/31/2024
8/31/2024
8/31/2024
0910–0594
0910–0686
0910–0721
8/31/2024
8/31/2024
8/31/2024
0910–0744
0910–0793
0910–0855
8/31/2024
8/31/2024
8/31/2024
0910–0856
8/31/2024
0910–0857
8/31/2024
0910–0900
0910–0901
8/31/2024
8/31/2024
of HHS authority to waive this
requirement for RWHAP Parts A, B, or
C recipients if a number of requirements
are met and a waiver request is
submitted to HRSA for approval.
RWHAP Part A, B, and C core medical
services waiver requests—if approved—
are effective for a 1-year budget period,
and apply to funds awarded under the
Minority AIDS Initiative.
Currently, for a core medical services
waiver request to be approved, (1) core
medical services must be available and
accessible to all individuals identified
and eligible for the RWHAP in the
recipient’s service area within 30 days,
without regard to payer source; (2) there
cannot be any AIDS Drug Assistance
Program (ADAP) waiting lists in the
recipient’s service area; and (3) a public
process to obtain input on the waiver
request from impacted communities,
including clients and RWHAP-funded
core medical services providers, on the
availability of core medical services and
the decision to request the waiver must
have occurred. The public process may
be a part of the same one used to seek
input on community needs as part of the
annual priority setting and resource
allocation, comprehensive planning,
statewide coordinated statement of
E:\FR\FM\01OCN1.SGM
01OCN1
Federal Register / Vol. 86, No. 188 / Friday, October 1, 2021 / Notices
need, public planning, and/or needs
assessment processes.
HRSA has simplified the waiver
request process for RWHAP Parts A, B,
and C recipients by revising and
replacing HRSA Policy Number 13–07:
Uniform Standard for Waiver of Core
Medical Services Requirement for
Grantees Under Part, A, B, and C. The
changes reduce the administrative
burden for recipients by lessening the
documentation they must submit to
HRSA when requesting a waiver. Under
this final policy, recipients are required
to submit a one-page ‘‘HRSA RWHAP
Core Medical Services Waiver Request
Attestation Form’’ to HRSA in lieu of
the multiple documents previously
required to submit a waiver request.
HRSA also revised the waiver request
submission deadlines. This final policy,
‘‘Waiver of the Ryan White HIV/AIDS
Program Core Medical Services
Expenditure Requirement,’’ replaces
HRSA Policy Number 13–07 effective
October 1, 2021.
In administering the RWHAP, HRSA
continually evaluates its policies and
processes, and considers making
updates where necessary to ensure
programmatic efficiency while
facilitating recipients’ ability to provide
care and support services to people with
HIV. To inform its policy evaluation and
development processes with
perspectives representative of the
communities served by the RWHAP,
HRSA welcomes and considers input
from stakeholders of the RWHAP,
including recipients, providers, people
with HIV, and the general public. To
that end, on April 20, 2021, HRSA
sought public input when it published
the proposed updates to the waiver
request process for RWHAP Parts A, B,
and C recipients in the Federal Register
(86 FR 20500), and released a listserv
message informing stakeholders where
to access and review the Federal
Register notice. In addition, during the
April 27, 2021, ‘‘HAB You Heard’’
RWHAP recipient webinar, HRSA
conducted a walkthrough of the
proposed policy, comparing and
contrasting it to the existent policy
outlined in HRSA Policy Number 13–
07. Subsequently, on August 20, 2021,
HRSA published a Federal Register
notice for 30-day public comment
period, and submitted the ICR to OMB
for review and approval.
Overview of Public Comments
In response to the proposed policy
published in 86 FR 20500, HRSA
received 52 responses from
stakeholders. The vast majority of
respondents were individuals from the
general public, followed by RWHAP
VerDate Sep<11>2014
18:04 Sep 30, 2021
Jkt 256001
recipients and HIV patient care
advocacy organizations. HRSA
considered all feedback in the
finalization of the policy, and a
discussion of the public comments is
included below.
Discussion of Public Comments on the
Proposed Policy
Availability of Core Medical Services,
ADAP Waiting Lists, and Evidence of a
Public Process
Public Comment: Commenters were
unanimously supportive of submitting a
one-page attestation form in lieu of the
multiple pages of supporting
documentation required per HRSA
Policy Number 13–07 because it would
reduce administrative burden. They
were equally supportive of the
stipulation that, if requested, recipients
would need to submit supportive
documentation to HRSA if requested.
Response: HRSA appreciates the
comments and agrees the new policy
will reduce burden for recipients, as
well as for HRSA as it reviews the
waiver applications. HRSA is finalizing
the policy as proposed. As such, when
submitting waiver requests, RWHAP
recipients will only need to submit the
one-page ‘‘HRSA RWHAP Core Medical
Services Waiver Request Attestation
Form’’ to HRSA in lieu of multiple
documents currently required to submit
a waiver request. HRSA may request
additional information or supporting
documentation. HRSA approximates
this process would require 4 hours per
response, representing a reduction of 1.5
hours when compared to the current
process, or a total of 88 hours across all
recipients expected to submit a waiver
application.
Submission Deadlines
Public Comment: Commenters were
supportive of the proposed changes
regarding waiver request submissions
deadlines. One commenter expressed
some concern that specific submission
deadlines may reduce flexibility for
some recipients and may not take into
account the urgency of a potential
waiver in the case of an emergency or
unexpected situation on the part of the
recipient. The commenter
recommended that HRSA adequately
advertise this tenet of the policy and
evaluate the deadlines to ensure this
change does not adversely impact
recipients.
Response: HRSA will finalize the
policy as proposed by requiring specific
submission deadlines. RWHAP Part A
recipients will need to submit the
waiver request as an attachment with
the grant application or non-competing
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
54459
continuation (NCC) progress report.
RWHAP Part B recipients will need to
submit the waiver request either in
advance of the grant application, with
the grant application, with the
mandatory NCC progress report, or up to
4 months into the grant award budget
period for which the waiver is being
requested. RWHAP Part C recipients
will need to submit the waiver request
as an attachment with the grant
application or the mandatory NCC
progress report. HRSA thanks the
commenters for their input, and will
monitor the impact of the new policy on
the RWHAP in order to ensure
recipients’ ability to timely submit
waiver requests and their ability to
provide care and support services to
people with HIV.
Concluding Points
HRSA continues to find opportunities
to streamline its policies and processes
to facilitate RWHAP recipients’ ability
to continue to deliver quality care and
support services to people with HIV,
while increasing HRSA’s efficiency in
administering the program. Given the
participation of RWHAP stakeholders in
the public process, HRSA believes
HRSA Policy Number 21–01 titled
‘‘Waiver of the Ryan White HIV/AIDS
Program Core Medical Services
Expenditure Requirement’’ meets the
overall goal and objective of the
RWHAP, and is inclusive of the
perspectives of stakeholders, while
reducing burden to RWHAP recipients.
HRSA expects a period of adjustment to
the new process. To that end, HRSA
will provide timely technical assistance
and other resources to assist recipients
with the transition to and
implementation of the final policy.
Recipients are encouraged to contact
HRSA at RWHAPPolicy@hrsa.gov for
questions or feedback on the new
process.
HRSA remains committed to
supporting RWHAP recipients in their
provision of care and support services to
people with HIV. The finalization of
HRSA Policy Number 21–01, which
reduces burden for recipients requesting
a waiver of the Core Medical Services
expenditure requirement, is another
step indicative of this commitment.
The final policy is set forth below.
Upon its Effective Date of October 1,
2021, the policy replaces HRSA Policy
Number 13–07.
E:\FR\FM\01OCN1.SGM
01OCN1
54460
Federal Register / Vol. 86, No. 188 / Friday, October 1, 2021 / Notices
Waiver of the Ryan White HIV/AIDS
Program Core Medical Services
Expenditure Requirement
Policy Notice 21–01
Replaces Policy Number 13–07
Scope of Coverage
HRSA HIV/AIDS Bureau RWHAP Parts
A, B, and C
Requirements
A HRSA RWHAP Part A, B, or C
recipient must meet a number of
requirements and submit a waiver
request to HRSA to receive a waiver of
the core medical services expenditure
requirement. First, core medical services
must be available and accessible to all
individuals identified and eligible for
the RWHAP in the recipient’s service
area within 30 days. Access to core
medical services must be without regard
to payer source and without the need to
spend at least 75 percent of funds
remaining from the recipient’s RWHAP
award after statutory permissible
amounts for administrative and CQM
are reserved. Second, the HRSA
RWHAP recipient must ensure there are
no ADAP waiting lists in its service
area. Third, a public process to obtain
input on the waiver request must have
occurred. This process must seek input
from impacted communities, including
clients and RWHAP-funded core
medical services providers on the
availability of core medical services and
the decision to request the waiver. The
public process may be a part of the same
one used to seek input on community
needs as part of the annual priority
setting and resource allocation,
comprehensive planning, statewide
coordinated statement of need, public
planning, and/or needs assessment
processes.
Requesting a Waiver
To request a waiver, the Chief Elected
Official, Chief Executive Officer, or a
VerDate Sep<11>2014
18:04 Sep 30, 2021
Jkt 256001
designee of either must complete and
submit the HRSA RWHAP Core Medical
Services Waiver Request Attestation
Form (appended below) to HRSA. The
form should be submitted according to
the applicable deadlines and methods
for submission outlined below. By
completing and submitting this form,
the Chief Elected Official, Chief
Executive Officer, or a designee of either
attests to meeting the requirements
outlined above and agrees to provide
supportive evidence to HRSA upon
request. No other documentation is
required to be submitted with the HRSA
RWHAP Core Medical Services Waiver
Request Attestation Form.
Deadlines for Submitting Waiver
Requests
HRSA RWHAP Part A Waiver Requests
A HRSA RWHAP Part A recipient’s
request for a waiver should be
submitted as an attachment with the
grant application or the mandatory NCC
progress report, if applicable. In each
case, waiver requests do not count
towards the submission page limit.
Requests for waivers should not be
submitted prior to the grant application
or mandatory NCC progress report, nor
should they be submitted after the start
of the grant award budget period for
which the waiver is being requested.
HRSA RWHAP Part B Waiver Requests
A HRSA RWHAP Part B recipient’s
request for a waiver may be submitted
either in advance of the grant
application, as an attachment to the
grant application, with the mandatory
NCC progress report, or up to 4 months
into the grant award budget period for
which the waiver is being requested.
HRSA RWHAP Part C Waiver Requests
A HRSA RWHAP Part C recipient’s
request for a waiver should be
submitted as an attachment to the grant
application or the mandatory NCC
progress report. Requests for waivers
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
should not be submitted prior to the
grant application or mandatory NCC
progress report, nor should they be
submitted after the start of the grant
award budget period for which the
waiver is being requested.
Methods for Submitting Waiver
Requests
Waiver requests submitted with grant
applications must be submitted through
www.grants.gov. Waiver requests
submitted with the mandatory NCC
progress report must be submitted
through the HRSA Electronic
Handbooks (EHB). For waiver requests
that are not submitted with grant
applications, and not submitted with
the mandatory NCC progress report, a
recipient must notify its HRSA project
officer of its intention to request a
waiver. The project officer will initiate
a Request for Information in the EHB.
The recipient must respond to the EHB
task consistent with the deadlines for
submitting waiver requests outlined
above.
Waiver Review and Notification
Process
HRSA will review requests and notify
recipients of waiver approval or denial
within 4 weeks of receipt of the request.
Approved core medical services
waivers will be effective for the 1-year
budget period for which it is approved;
recipients must submit a new request
for each budget period. A recipient
approved for a core medical services
waiver is not required to implement the
approved waiver if it is no longer
needed.
This guidance does not have the force
and effect of law and is not meant to
bind the public in any way, except as
authorized by law or as incorporated
into a contract. It is intended only to
provide clarity to the public regarding
existing requirements under the law or
agency policies.
BILLING CODE 4165–01–P
E:\FR\FM\01OCN1.SGM
01OCN1
VerDate Sep<11>2014
18:04 Sep 30, 2021
Jkt 256001
PO 00000
Frm 00043
Fmt 4703
Sfmt 4725
E:\FR\FM\01OCN1.SGM
01OCN1
54461
EN01OC21.000
Federal Register / Vol. 86, No. 188 / Friday, October 1, 2021 / Notices
54462
Federal Register / Vol. 86, No. 188 / Friday, October 1, 2021 / Notices
Diana Espinosa,
Acting Administrator.
[FR Doc. 2021–21241 Filed 9–30–21; 8:45 am]
BILLING CODE 4165–15–C
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Center for Indigenous Innovation and
Health Equity Tribal Advisory
Committee; Solicitation of
Nominations for Delegates
Office of Minority Health,
Office of the Secretary, Department of
Health and Human Services.
ACTION: Notice of solicitation of
nominations for delegates for the Center
for Indigenous Innovation and Health
Equity Tribal Advisory Committee.
AGENCY:
The U.S. Department of
Health and Human Services (HHS)
Office of Minority Health (OMH) hereby
gives notice that OMH is establishing a
Center for Indigenous Innovation and
Health Equity Tribal Advisory
Committee (CIIHE TAC) and accepting
nominations of qualified candidates to
serve as primary and alternate delegates
for the CIIHE TAC, in alignment with
the 12 geographic areas served by the
Indian Health Service (IHS).
DATES: Nomination letters for the CIIHE
TAC must be sent to the address noted
below no later than 6:00 p.m. EST on
October 29, 2021.
ADDRESSES: All nominations should be
emailed to: Violet Woo, Designated
Federal Officer for the CIIHE TAC, at
Violet.Woo@hhs.gov. Please use the
subject line ‘‘OMH CIIHE Tribal
Advisory Committee’’.
FOR FURTHER INFORMATION CONTACT: For
information and guidance about the
nomination process for CIIHE TAC
delegates, please contact Violet Woo,
Designated Federal Officer at
Violet.Woo@hhs.gov. CIIHE TAC
nomination guidance and sample
nomination letters also are available on
the OMH website’s Tribal Leader Letters
section: https://
www.minorityhealth.hhs.gov/omh/
browse.aspx?lvl=3&lvlid=62#triballeader-letters.
SUPPLEMENTARY INFORMATION:
Authorized under Section 1707 of the
Public Health Service Act, 42 U.S.C.
300u–6, as amended, the mission of
OMH is to improve the health of racial
and ethnic minority populations
through the development of health
policies and programs that help
eliminate health disparities. OMH
awards and other activities are intended
to support the identification of effective
policies, programs, and practices for
SUMMARY:
VerDate Sep<11>2014
18:04 Sep 30, 2021
Jkt 256001
improving health outcomes and to
promote the sustainability and
dissemination of these approaches.
Under the authority of Public Law
116–260 (2021 Consolidated
Appropriations Act), Congress directed
OMH to create a CIIHE to support
research, education, service, and policy
development advancing Indigenous
solutions that ultimately address health
disparities in American Indian/Alaska
Native (AI/AN) and Native Hawaiian
and Pacific Islander (NHPI) populations.
OMH is establishing the CIIHE TAC to
ensure that Tribal Leaders have
meaningful and timely input in the
development of the priorities and
activities established to address the
focus areas of the CIIHE. The CIIHE TAC
shall support, but not supplant,
government-to-government consultation
activities that OMH undertakes.
TAC Membership: The CIIHE TAC
will consist of 16 delegate positions:
One from each of the 12 geographic
areas served by the Indian Health
Service and four National At-Large
Member positions.
Alaska Area
Albuquerque Area
Bemidji Area
Billings Area
California Area
Great Plains Area
Nashville Area
Navajo Area
Oklahoma Area
Phoenix Area
Portland Area
Tucson Area
National At-Large Members (4)
OMH recommends a two (2) year term
length for each delegate, but delegates’
term length will be established by the
TAC’s charter.
Eligibility: The CIIHE TAC delegates
must be: (1) Elected tribal officials from
a federally recognized tribe acting in
their official capacity as elected officials
of their tribe, with authority to act on
behalf of the tribe; or (2) individuals
designated by an elected tribal official.
Designees must have the authority to act
on behalf of the tribal official and the
tribe and be qualified to represent the
views of the AI/AN tribes in the area
from which they are nominated. No
delegate of the CIIHE TAC may be an
employee of the federal government.
Nomination Procedures: CIIHE TAC
candidates must be nominated by an
elected tribal leader. The nomination
letter must be on tribal letterhead and
signed by an elected tribal leader, and
must include the following information:
• Name of the nominee
• Nominee’s official title
• Name of the nominee’s tribe
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
• Date of nominee’s election to official
tribal position and term length
• Nominee’s contact information
(mailing address, phone, and email)
• Nominee’s expertise that is relevant to
the CIIHE TAC
• Name of tribal leader submitting the
nomination
• Official title of tribal leader
submitting the nomination
• Contact information for tribal leader
submitting the nomination and/or
administrative office for tribal
government
CIIHE TAC nomination guidance and
sample nomination letters are available
on the OMH website’s Tribal Leader
Letters section: https://
www.minorityhealth.hhs.gov/omh/
browse.aspx?lvl=3&lvlid=62#triballeader-letters.
Selection Process: OMH is responsible
for selecting and finalizing CIIHE TAC
members.
Eligible nominees will be considered
in the following priority order:
1. Tribal President/Chairperson/
Governor
2. Tribal Vice-President/ViceChairperson/Lt. Governor
3. Elected or Appointed Tribal Official
4. Designated Tribal Official with
authority to act on behalf of Tribal
leader
In the event that there is more than
one nomination for a given IHS area,
OMH will make a determination of
representation based on submitted
nomination materials.
Nominees will be notified of the
status of delegate selection in November
2021.
Dated: September 24, 2021.
Violet Woo,
Designated Federal Officer, Center for
Indigenous Innovation and Health Equity
Tribal Advisory Committee.
[FR Doc. 2021–21253 Filed 9–30–21; 8:45 am]
BILLING CODE 4150–29–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Indian Health Service
Request for Public Comment: 60 Day
Notice for Extension of Fast Track
Generic Clearance for the Collection of
Qualitative Feedback on Agency
Service Delivery: IHS Customer
Service Satisfaction and Similar
Surveys
Indian Health Service, HHS.
Notice and request for
comments. Request for extension of
approval.
AGENCY:
ACTION:
E:\FR\FM\01OCN1.SGM
01OCN1
Agencies
[Federal Register Volume 86, Number 188 (Friday, October 1, 2021)]
[Notices]
[Pages 54458-54462]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-21241]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Health Resources and Services Administration
Final Policy: Updates to Uniform Standard for Waiver of the Ryan
White HIV/AIDS Program Core Medical Services Expenditure Requirement
AGENCY: Health Resources and Services Administration (HRSA), Department
of Health and Human Services (HHS).
ACTION: Notice of final policy.
-----------------------------------------------------------------------
SUMMARY: The Ryan White HIV/AIDS Program (RWHAP) statute of the Public
Health Services Act requires that RWHAP Part A, B, and C recipients
expend not less than 75 percent of Parts A, B, and C grant funds on
core medical services for individuals with HIV/AIDS identified and
eligible under the statute, after reserving statutory permissible
amounts for administrative and clinical quality management (CQM) costs.
The statute also grants the Secretary of HHS authority to waive this
requirement if certain requirements are met. HRSA has simplified the
process for RWHAP Part A, B, and C recipients to request a waiver of
the core medical services expenditure amount requirement by replacing
HRSA Policy Number 13-07, ``Uniform Standard for Waiver of Core Medical
Services Requirement for Grantees Under Parts, A, B, and C'' with
Policy Notice 21-01, ``Waiver of the Ryan White HIV/AIDS Program Core
Medical Services Expenditure Requirement.''
DATES: The final policy is effective on October 1, 2021.
FOR FURTHER INFORMATION CONTACT: Lieutenant Commander Emeka Egwim, U.S.
Public Health Service, Senior Policy Analyst, Division of Policy &
Data, HRSA, HIV/AIDS Bureau, 5600 Fishers Lane, Rockville, MD 20857,
Phone: (301) 945-9637 or by emailing [email protected]. When
requesting information, please include this Federal Register notice
title for reference.
SUPPLEMENTARY INFORMATION: The RWHAP statute also grants the Secretary
of HHS authority to waive this requirement for RWHAP Parts A, B, or C
recipients if a number of requirements are met and a waiver request is
submitted to HRSA for approval. RWHAP Part A, B, and C core medical
services waiver requests--if approved--are effective for a 1-year
budget period, and apply to funds awarded under the Minority AIDS
Initiative.
Currently, for a core medical services waiver request to be
approved, (1) core medical services must be available and accessible to
all individuals identified and eligible for the RWHAP in the
recipient's service area within 30 days, without regard to payer
source; (2) there cannot be any AIDS Drug Assistance Program (ADAP)
waiting lists in the recipient's service area; and (3) a public process
to obtain input on the waiver request from impacted communities,
including clients and RWHAP-funded core medical services providers, on
the availability of core medical services and the decision to request
the waiver must have occurred. The public process may be a part of the
same one used to seek input on community needs as part of the annual
priority setting and resource allocation, comprehensive planning,
statewide coordinated statement of
[[Page 54459]]
need, public planning, and/or needs assessment processes.
HRSA has simplified the waiver request process for RWHAP Parts A,
B, and C recipients by revising and replacing HRSA Policy Number 13-07:
Uniform Standard for Waiver of Core Medical Services Requirement for
Grantees Under Part, A, B, and C. The changes reduce the administrative
burden for recipients by lessening the documentation they must submit
to HRSA when requesting a waiver. Under this final policy, recipients
are required to submit a one-page ``HRSA RWHAP Core Medical Services
Waiver Request Attestation Form'' to HRSA in lieu of the multiple
documents previously required to submit a waiver request.
HRSA also revised the waiver request submission deadlines. This
final policy, ``Waiver of the Ryan White HIV/AIDS Program Core Medical
Services Expenditure Requirement,'' replaces HRSA Policy Number 13-07
effective October 1, 2021.
In administering the RWHAP, HRSA continually evaluates its policies
and processes, and considers making updates where necessary to ensure
programmatic efficiency while facilitating recipients' ability to
provide care and support services to people with HIV. To inform its
policy evaluation and development processes with perspectives
representative of the communities served by the RWHAP, HRSA welcomes
and considers input from stakeholders of the RWHAP, including
recipients, providers, people with HIV, and the general public. To that
end, on April 20, 2021, HRSA sought public input when it published the
proposed updates to the waiver request process for RWHAP Parts A, B,
and C recipients in the Federal Register (86 FR 20500), and released a
listserv message informing stakeholders where to access and review the
Federal Register notice. In addition, during the April 27, 2021, ``HAB
You Heard'' RWHAP recipient webinar, HRSA conducted a walkthrough of
the proposed policy, comparing and contrasting it to the existent
policy outlined in HRSA Policy Number 13-07. Subsequently, on August
20, 2021, HRSA published a Federal Register notice for 30-day public
comment period, and submitted the ICR to OMB for review and approval.
Overview of Public Comments
In response to the proposed policy published in 86 FR 20500, HRSA
received 52 responses from stakeholders. The vast majority of
respondents were individuals from the general public, followed by RWHAP
recipients and HIV patient care advocacy organizations. HRSA considered
all feedback in the finalization of the policy, and a discussion of the
public comments is included below.
Discussion of Public Comments on the Proposed Policy
Availability of Core Medical Services, ADAP Waiting Lists, and Evidence
of a Public Process
Public Comment: Commenters were unanimously supportive of
submitting a one-page attestation form in lieu of the multiple pages of
supporting documentation required per HRSA Policy Number 13-07 because
it would reduce administrative burden. They were equally supportive of
the stipulation that, if requested, recipients would need to submit
supportive documentation to HRSA if requested.
Response: HRSA appreciates the comments and agrees the new policy
will reduce burden for recipients, as well as for HRSA as it reviews
the waiver applications. HRSA is finalizing the policy as proposed. As
such, when submitting waiver requests, RWHAP recipients will only need
to submit the one-page ``HRSA RWHAP Core Medical Services Waiver
Request Attestation Form'' to HRSA in lieu of multiple documents
currently required to submit a waiver request. HRSA may request
additional information or supporting documentation. HRSA approximates
this process would require 4 hours per response, representing a
reduction of 1.5 hours when compared to the current process, or a total
of 88 hours across all recipients expected to submit a waiver
application.
Submission Deadlines
Public Comment: Commenters were supportive of the proposed changes
regarding waiver request submissions deadlines. One commenter expressed
some concern that specific submission deadlines may reduce flexibility
for some recipients and may not take into account the urgency of a
potential waiver in the case of an emergency or unexpected situation on
the part of the recipient. The commenter recommended that HRSA
adequately advertise this tenet of the policy and evaluate the
deadlines to ensure this change does not adversely impact recipients.
Response: HRSA will finalize the policy as proposed by requiring
specific submission deadlines. RWHAP Part A recipients will need to
submit the waiver request as an attachment with the grant application
or non-competing continuation (NCC) progress report. RWHAP Part B
recipients will need to submit the waiver request either in advance of
the grant application, with the grant application, with the mandatory
NCC progress report, or up to 4 months into the grant award budget
period for which the waiver is being requested. RWHAP Part C recipients
will need to submit the waiver request as an attachment with the grant
application or the mandatory NCC progress report. HRSA thanks the
commenters for their input, and will monitor the impact of the new
policy on the RWHAP in order to ensure recipients' ability to timely
submit waiver requests and their ability to provide care and support
services to people with HIV.
Concluding Points
HRSA continues to find opportunities to streamline its policies and
processes to facilitate RWHAP recipients' ability to continue to
deliver quality care and support services to people with HIV, while
increasing HRSA's efficiency in administering the program. Given the
participation of RWHAP stakeholders in the public process, HRSA
believes HRSA Policy Number 21-01 titled ``Waiver of the Ryan White
HIV/AIDS Program Core Medical Services Expenditure Requirement'' meets
the overall goal and objective of the RWHAP, and is inclusive of the
perspectives of stakeholders, while reducing burden to RWHAP
recipients. HRSA expects a period of adjustment to the new process. To
that end, HRSA will provide timely technical assistance and other
resources to assist recipients with the transition to and
implementation of the final policy. Recipients are encouraged to
contact HRSA at [email protected] for questions or feedback on the
new process.
HRSA remains committed to supporting RWHAP recipients in their
provision of care and support services to people with HIV. The
finalization of HRSA Policy Number 21-01, which reduces burden for
recipients requesting a waiver of the Core Medical Services expenditure
requirement, is another step indicative of this commitment.
The final policy is set forth below. Upon its Effective Date of
October 1, 2021, the policy replaces HRSA Policy Number 13-07.
[[Page 54460]]
Waiver of the Ryan White HIV/AIDS Program Core Medical Services
Expenditure Requirement
Policy Notice 21-01
Replaces Policy Number 13-07
Scope of Coverage
HRSA HIV/AIDS Bureau RWHAP Parts A, B, and C
Requirements
A HRSA RWHAP Part A, B, or C recipient must meet a number of
requirements and submit a waiver request to HRSA to receive a waiver of
the core medical services expenditure requirement. First, core medical
services must be available and accessible to all individuals identified
and eligible for the RWHAP in the recipient's service area within 30
days. Access to core medical services must be without regard to payer
source and without the need to spend at least 75 percent of funds
remaining from the recipient's RWHAP award after statutory permissible
amounts for administrative and CQM are reserved. Second, the HRSA RWHAP
recipient must ensure there are no ADAP waiting lists in its service
area. Third, a public process to obtain input on the waiver request
must have occurred. This process must seek input from impacted
communities, including clients and RWHAP-funded core medical services
providers on the availability of core medical services and the decision
to request the waiver. The public process may be a part of the same one
used to seek input on community needs as part of the annual priority
setting and resource allocation, comprehensive planning, statewide
coordinated statement of need, public planning, and/or needs assessment
processes.
Requesting a Waiver
To request a waiver, the Chief Elected Official, Chief Executive
Officer, or a designee of either must complete and submit the HRSA
RWHAP Core Medical Services Waiver Request Attestation Form (appended
below) to HRSA. The form should be submitted according to the
applicable deadlines and methods for submission outlined below. By
completing and submitting this form, the Chief Elected Official, Chief
Executive Officer, or a designee of either attests to meeting the
requirements outlined above and agrees to provide supportive evidence
to HRSA upon request. No other documentation is required to be
submitted with the HRSA RWHAP Core Medical Services Waiver Request
Attestation Form.
Deadlines for Submitting Waiver Requests
HRSA RWHAP Part A Waiver Requests
A HRSA RWHAP Part A recipient's request for a waiver should be
submitted as an attachment with the grant application or the mandatory
NCC progress report, if applicable. In each case, waiver requests do
not count towards the submission page limit. Requests for waivers
should not be submitted prior to the grant application or mandatory NCC
progress report, nor should they be submitted after the start of the
grant award budget period for which the waiver is being requested.
HRSA RWHAP Part B Waiver Requests
A HRSA RWHAP Part B recipient's request for a waiver may be
submitted either in advance of the grant application, as an attachment
to the grant application, with the mandatory NCC progress report, or up
to 4 months into the grant award budget period for which the waiver is
being requested.
HRSA RWHAP Part C Waiver Requests
A HRSA RWHAP Part C recipient's request for a waiver should be
submitted as an attachment to the grant application or the mandatory
NCC progress report. Requests for waivers should not be submitted prior
to the grant application or mandatory NCC progress report, nor should
they be submitted after the start of the grant award budget period for
which the waiver is being requested.
Methods for Submitting Waiver Requests
Waiver requests submitted with grant applications must be submitted
through www.grants.gov. Waiver requests submitted with the mandatory
NCC progress report must be submitted through the HRSA Electronic
Handbooks (EHB). For waiver requests that are not submitted with grant
applications, and not submitted with the mandatory NCC progress report,
a recipient must notify its HRSA project officer of its intention to
request a waiver. The project officer will initiate a Request for
Information in the EHB. The recipient must respond to the EHB task
consistent with the deadlines for submitting waiver requests outlined
above.
Waiver Review and Notification Process
HRSA will review requests and notify recipients of waiver approval
or denial within 4 weeks of receipt of the request.
Approved core medical services waivers will be effective for the 1-
year budget period for which it is approved; recipients must submit a
new request for each budget period. A recipient approved for a core
medical services waiver is not required to implement the approved
waiver if it is no longer needed.
This guidance does not have the force and effect of law and is not
meant to bind the public in any way, except as authorized by law or as
incorporated into a contract. It is intended only to provide clarity to
the public regarding existing requirements under the law or agency
policies.
BILLING CODE 4165-01-P
[[Page 54461]]
[GRAPHIC] [TIFF OMITTED] TN01OC21.000
[[Page 54462]]
Diana Espinosa,
Acting Administrator.
[FR Doc. 2021-21241 Filed 9-30-21; 8:45 am]
BILLING CODE 4165-15-C